Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Recent progress in stimuli‐activable metallo‐prodrugs for cancer therapy
View through CrossRef
AbstractThe clinical approval of platinum‐based drugs has prompted the development of novel metallo‐complexes during the last several decades, while severe problems, especially for poor water solubility, drug resistance and toxicity in patients, greatly hindered the clinical trials and curative efficacy. To address these issues, the concept of metallo‐prodrugs has been proposed for oncology. Some stimuli‐activable metallo‐prodrugs provide new insights for designing and preparing site‐specific prodrugs with maximized therapeutic efficacy and negligible unfavorable by‐effects. In this review, recent progress in stimuli‐activable metallo‐prodrugs in the past 20 years has been overviewed, where endogenous and exogenous stimuli have been involved. Typical examples of smart stimuli‐activable metallo‐prodrugs are discussed regarding to their molecular structure, activation mechanism, and promising biomedical applications. In the end, challenges and future perspectives in metallo‐prodrugs have been discussed.
Title: Recent progress in stimuli‐activable metallo‐prodrugs for cancer therapy
Description:
AbstractThe clinical approval of platinum‐based drugs has prompted the development of novel metallo‐complexes during the last several decades, while severe problems, especially for poor water solubility, drug resistance and toxicity in patients, greatly hindered the clinical trials and curative efficacy.
To address these issues, the concept of metallo‐prodrugs has been proposed for oncology.
Some stimuli‐activable metallo‐prodrugs provide new insights for designing and preparing site‐specific prodrugs with maximized therapeutic efficacy and negligible unfavorable by‐effects.
In this review, recent progress in stimuli‐activable metallo‐prodrugs in the past 20 years has been overviewed, where endogenous and exogenous stimuli have been involved.
Typical examples of smart stimuli‐activable metallo‐prodrugs are discussed regarding to their molecular structure, activation mechanism, and promising biomedical applications.
In the end, challenges and future perspectives in metallo‐prodrugs have been discussed.
Related Results
Recent Advances in Prodrug Approach over Conventional Drug Therapy
Recent Advances in Prodrug Approach over Conventional Drug Therapy
Background:
Prodrugs represent a strategically designed category of medicinal compounds
aimed at optimizing drug pharmacokinetics. By modifying the pharmacological action of the
dr...
Newly Developed Prodrugs and Prodrugs in Development; an Insight of the Recent Years
Newly Developed Prodrugs and Prodrugs in Development; an Insight of the Recent Years
Background: The design and development of prodrugs is the most common and effective strategy to overcome pharmacokinetic and pharmacodynamic drawbacks of active drugs. A respected ...
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Abstract
Introduction
Cancer patients face a venous thromboembolism (VTE) risk that is up to 50 times higher compared to individuals without cancer. In 2010, direct oral anticoagul...
Intramolecular Processes and Their Applications in Prodrugs Approaches- Experimental and Computational Studies
Intramolecular Processes and Their Applications in Prodrugs Approaches- Experimental and Computational Studies
This review supplies the reader with a detailed overview on the utilization of intramolecular processes
for a design and synthesis of prodrugs. It is well known that a respected nu...
Use of prodrugs in cancer therapy - A Review
Use of prodrugs in cancer therapy - A Review
A prodrug is a medicine that is primarily used after administration, that is metabolized into a pharmacologically active drug. A prodrug is generally a precursor form of a drug. A ...
International Breast Cancer Study Group (IBCSG)
International Breast Cancer Study Group (IBCSG)
This section provides current contact details and a summary of recent or ongoing clinical trials being coordinated by International Breast Cancer Study Group (IBCSG). Clinical tria...
Diagnostic Rate of the Cancer by BDORT Utilizing the Cancer Slide
Diagnostic Rate of the Cancer by BDORT Utilizing the Cancer Slide
Purpose:
To make a diagnosis of cancer with BDORT (resonance test), we can choose two methods. One is to use a chemical agent like Integrin α5β1 or Oncogene C-f...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract
Introduction
Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...